CZM’s eye attractiveness fades
18/06/24 -"Surprisingly, CZM slashed its full-year guidance yesterday. Greater Chinese exposure (marred by VBP roll-out delays and softer start to the summer peak season) and delayed interest rate cuts weighed ..."
Pages
65
Language
English
Published on
18/06/24
You may also be interested by these reports :
14/11/25
Sonova reported decent H1 results, with sales aligning with the company-compiled consensus. However, normalised EBITA did not meet expectations due ...
13/11/25
The Q3 results were somewhat ahead of expectations, and the 2025 guidance was maintained this time, after two downgrades earlier this year. This, ...
07/11/25
GN’s Q3 results fell short of expectations. Sales growth in Hearing and Gaming was nearly counterbalanced by weakness in Enterprise. Profitability ...
06/11/25
DiaSorin’s Q3 results did not meet expectations, with all segments underperforming except for immunodiagnostics. As a result, management has lowered ...